Compromise on length of pharmaceutical companies’ monopolies on new drugs could create two tracks on future drug pricing, insider saysA dozen Pacific countries closed in on a sweeping free trade pact on Sunday in Atlanta, after a breakthrough over how long a monopoly pharmaceutical companies should be given on new biotech drugs.